IndyGeneUS AI

Washington, United States

IndyGeneUS AI is a genomics company building a digital blockchain-encrypted bio-bank.

$50K raised

Dec 2022

Pre-Seed

Biotechnology Health Care Life Science Medical

Top Investors

Johnson & Johnson IsimoVest Venture Capital Partners Merck Global Health Innovation Fund Voltron Capital Johnson & Johnson Robotics and Digital Solutions

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about IndyGeneUS AI

How much funding has IndyGeneUS AI raised?

IndyGeneUS AI has raised $50K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2022.

Who are IndyGeneUS AI's investors?

IndyGeneUS AI's investors include Johnson & Johnson, IsimoVest Venture Capital Partners, Merck Global Health Innovation Fund, Voltron Capital, Johnson & Johnson Robotics and Digital Solutions.

Where is IndyGeneUS AI headquartered?

IndyGeneUS AI is headquartered in Washington, United States.

What does IndyGeneUS AI do?

IndyGeneUS AI is a genomics company building a digital blockchain-encrypted bio-bank.

What stage is IndyGeneUS AI at?

IndyGeneUS AI is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 16, 2022.

MLA

"IndyGeneUS AI — Funding & Investors." VCBacked, December 16, 2022, https://www.vcbacked.co/company/indygeneus-ai. Accessed July 3, 2026.

APA

VCBacked. (2022). IndyGeneUS AI — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/indygeneus-ai

Wikipedia (cite web)

{{cite web |title=IndyGeneUS AI — Funding & Investors |url=https://www.vcbacked.co/company/indygeneus-ai |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 16, 2022.